Actively Recruiting
Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
Led by Xi'an No.3 Hospital · Updated on 2023-12-15
120
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, and currently, manual repositioning techniques are often used for treatment. However, up to 30%-50% of patients may experience residual symptoms such as non-rotational dizziness, heaviness, instability, and emotional disturbances even after successful repositioning, which significantly impacts their daily functioning and quality of life. Electroacupuncture therapy has been proven to be an effective treatment for dizziness and has been applied to various vestibular disorder patients. However, the efficacy of electroacupuncture on the residual effects of successfully repositioned BPPV patients remains unclear. This study aims to explore the effectiveness of three regimens: electroacupuncture, betahistine in patients with residual symptoms after successful manual repositioning.
CONDITIONS
Official Title
Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of benign paroxysmal positional vertigo (BPPV) with successful repositioning maneuver
- Residual symptoms such as dizziness, head heaviness, unsteady gait, or floating sensation after repositioning
- No significant communication barriers or vision problems
- Patient and family agree to the treatment plan
You will not qualify if you...
- Other ear diseases or history of head trauma or surgery
- Patients who are weak or unable to tolerate treatment
- Pregnant women
- Prior vestibular rehabilitation training before this treatment
- Joint diseases affecting balance or walking
- History of brain organic diseases like tumors, stroke, or severe neurological disorders
- Incomplete data or withdrawal from treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xi'an No3 Hospital
Xi'an, China
Actively Recruiting
Research Team
M
Mingze Chang, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here